A detailed history of Lakewood Capital Management, LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Lakewood Capital Management, LP holds 112,740 shares of CRL stock, worth $22.8 Million. This represents 2.51% of its overall portfolio holdings.

Number of Shares
112,740
Previous 117,740 4.25%
Holding current value
$22.8 Million
Previous $27.8 Million 9.75%
% of portfolio
2.51%
Previous 2.36%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$203.52 - $273.43 $1.02 Million - $1.37 Million
-5,000 Reduced 4.25%
112,740 $30.5 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $4.94 Million - $7.17 Million
30,000 Added 34.19%
117,740 $27.8 Million
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $3.55 Million - $4.5 Million
-18,000 Reduced 17.02%
87,740 $19.1 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $7.12 Million - $9.77 Million
-39,000 Reduced 26.94%
105,740 $20.8 Million
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $13.8 Million - $20.5 Million
67,640 Added 87.73%
144,740 $31 Million
Q1 2022

May 16, 2022

BUY
$255.51 - $362.11 $19.7 Million - $27.9 Million
77,100 New
77,100 $21.9 Million
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $46.2 Million - $56.8 Million
-124,000 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$294.17 - $371.65 $11.5 Million - $14.5 Million
-39,000 Reduced 23.93%
124,000 $45.9 Million
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $3.5 Million - $4.19 Million
-14,000 Reduced 7.91%
163,000 $47.2 Million
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $4.66 Million - $5.31 Million
-21,000 Reduced 10.61%
177,000 $44.2 Million
Q3 2020

Nov 16, 2020

SELL
$175.56 - $226.45 $4.74 Million - $6.11 Million
-27,000 Reduced 12.0%
198,000 $44.8 Million
Q2 2020

Aug 14, 2020

BUY
$118.84 - $189.72 $26.7 Million - $42.7 Million
225,000 New
225,000 $39.2 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.3B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Lakewood Capital Management, LP Portfolio

Follow Lakewood Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lakewood Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lakewood Capital Management, LP with notifications on news.